Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors
Interventions: DRUG: Paclitaxel Micelles for Injection|DRUG: Paclitaxel injection
Sponsor: First Affiliated Hospital of Zhejiang University
Collaborators: Hangzhou Dihua Biotechnology Co., LTD.